Predicting the next pandemic: VACCELERATE ranking of the WorldHealth Organization's Blueprint forAction toPreventEpidemics
- PMID: 38061408
- DOI: 10.1016/j.tmaid.2023.102676
Predicting the next pandemic: VACCELERATE ranking of the WorldHealth Organization's Blueprint forAction toPreventEpidemics
Abstract
Introduction: The World Health Organization (WHO)'s Research and Development (R&D) Blueprint for Action to Prevent Epidemics, a plan of action, highlighted several infectious diseases as crucial targets for prevention. These infections were selected based on a thorough assessment of factors such as transmissibility, infectivity, severity, and evolutionary potential. In line with this blueprint, the VACCELERATE Site Network approached infectious disease experts to rank the diseases listed in the WHO R&D Blueprint according to their perceived risk of triggering a pandemic. VACCELERATE is an EU-funded collaborative European network of clinical trial sites, established to respond to emerging pandemics and enhance vaccine development capabilities.
Methods: Between February and June 2023, a survey was conducted using an online form to collect data from members of the VACCELERATE Site Network and infectious disease experts worldwide. Participants were asked to rank various pathogens based on their perceived risk of causing a pandemic, including those listed in the WHO R&D Blueprint and additional pathogens.
Results: A total of 187 responses were obtained from infectious disease experts representing 57 countries, with Germany, Spain, and Italy providing the highest number of replies. Influenza viruses received the highest rankings among the pathogens, with 79 % of participants including them in their top rankings. Disease X, SARS-CoV-2, SARS-CoV, and Ebola virus were also ranked highly. Hantavirus, Lassa virus, Nipah virus, and henipavirus were among the bottom-ranked pathogens in terms of pandemic potential.
Conclusion: Influenza, SARS-CoV, SARS-CoV-2, and Ebola virus were found to be the most concerning pathogens with pandemic potential, characterised by transmissibility through respiratory droplets and a reported history of epidemic or pandemic outbreaks.
Keywords: Disease X; Ebola virus; Infectious disease; Influenza viruses; Pandemic; SARS-CoV; SARS-CoV-2; WHO R&D Blueprint for action to prevent epidemics.
Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest Authors reports no conflicts of interest regarding the current manuscript.
Similar articles
-
VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe.Vaccine. 2023 Jun 13;41(26):3915-3922. doi: 10.1016/j.vaccine.2023.05.006. Epub 2023 May 18. Vaccine. 2023. PMID: 37210309 Free PMC article.
-
Global research trends of World Health Organization's top eight emerging pathogens.Global Health. 2017 Feb 8;13(1):9. doi: 10.1186/s12992-017-0233-9. Global Health. 2017. PMID: 28179007 Free PMC article. Review.
-
Preparing the developing world for the next pandemic: Evidence from China's R&D blueprint for emerging infectious diseases.J Infect Public Health. 2024 Oct;17(10):102538. doi: 10.1016/j.jiph.2024.102538. Epub 2024 Sep 10. J Infect Public Health. 2024. PMID: 39270469
-
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment.Vaccine. 2022 Jul 29;40(31):4090-4097. doi: 10.1016/j.vaccine.2022.05.022. Epub 2022 Jun 2. Vaccine. 2022. PMID: 35659449 Free PMC article.
-
Changing patterns of infectious diseases in children during the COVID-19 pandemic.Front Cell Infect Microbiol. 2023 Jun 29;13:1200617. doi: 10.3389/fcimb.2023.1200617. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37457965 Free PMC article. Review.
Cited by
-
Almost 80 Years After Hiroshima and Nagasaki: Are World Governments and Healthcare Systems Ready for a Nuclear War?J Prev Med Public Health. 2025 Mar;58(2):227-229. doi: 10.3961/jpmph.24.577. Epub 2024 Dec 17. J Prev Med Public Health. 2025. PMID: 39901759 Free PMC article.
-
Predicting pathogen evolution and immune evasion in the age of artificial intelligence.Comput Struct Biotechnol J. 2025 Mar 28;27:1370-1382. doi: 10.1016/j.csbj.2025.03.044. eCollection 2025. Comput Struct Biotechnol J. 2025. PMID: 40235636 Free PMC article. Review.
-
Evolution of SARS-CoV-2 epidemics in pediatric population in Liguria (North-west Italy) from March 2020 to December 2022: what could we have learned?J Prev Med Hyg. 2025 Jan 31;65(4):E483-E490. doi: 10.15167/2421-4248/jpmh2024.65.4.3348. eCollection 2024 Dec. J Prev Med Hyg. 2025. PMID: 40026422 Free PMC article.
-
Preventive effect of Lianhua Qingwen capsule on close contacts of seasonal influenza in residential environments: protocol for a multicenter, randomized, double-blind, placebo-controlled study.J Thorac Dis. 2025 Apr 30;17(4):2623-2633. doi: 10.21037/jtd-24-1542. Epub 2025 Apr 28. J Thorac Dis. 2025. PMID: 40400963 Free PMC article.
-
Constructing a screening model to identify patients at high risk of hospital-acquired influenza on admission to hospital.Front Public Health. 2025 Apr 16;13:1495794. doi: 10.3389/fpubh.2025.1495794. eCollection 2025. Front Public Health. 2025. PMID: 40308921 Free PMC article.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous